European Leukemia Trial Registry
Trial: 2215-CL-0201

More Details
Short Title 2215-CL-0201
Trialgroup Keine Studiengruppe
Type of Trial randomized, mehrarmig, prospective, open-label
Disease Acute myeloid leukemia(AML) FLT3 Mutation
Age 18 - 70 Jahre
Status Active
Start of Recruitment 15.09.2017
Leader Müller-Tidow, Prof. Dr. med., Carsten
Shortprotocol Shortprotocol
created 08.03.2018 Student Studienregister
changed 20.12.2018 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org